H. Lundbeck A/S (CPH:HLUN.B)
43.08
-0.88 (-2.00%)
At close: Apr 28, 2026
H. Lundbeck Employees
H. Lundbeck had 5,039 employees as of December 31, 2025. The number of employees decreased by 404 or -7.42% compared to the previous year.
Employees
5,039
Change (1Y)
-404
Growth (1Y)
-7.42%
Revenue / Employee
4.89M DKK
Profits / Employee
633.46K DKK
Market Cap
41.81B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Novo Nordisk | 69,505 |
| Genmab | 2,973 |
| Coloplast | 16,983 |
| ALK-Abelló | 2,613 |
| Demant | 26,704 |
| Zealand Pharma | 501 |
| Ambu A/S | 5,200 |
| Bavarian Nordic | 1,692 |
H. Lundbeck News
- 5 weeks ago - H. Lundbeck Transcript: AGM 2026 - Transcripts
- 5 months ago - H. Lundbeck Transcript: Jefferies Global Healthcare Conference - Transcripts
- 5 months ago - H. Lundbeck Launches Bid for Avadel in Move to Scuttle Alkermes Deal - WSJ
- 5 months ago - H. Lundbeck Earnings Call Transcript: Q3 2025 - Transcripts
- 9 months ago - H. Lundbeck Earnings Call Transcript: Q2 2025 - Transcripts
- 1 year ago - H. Lundbeck Earnings Call Transcript: Q1 2025 - Transcripts
- 1 year ago - H. Lundbeck Transcript: AGM 2025 - Transcripts
- 1 year ago - Lundbeck's potential treatment for Multiple System Atrophy granted Orphan Drug Designation in Japan - PRNewsWire